Literature DB >> 16837369

Within-day variation of bioelectrical resistance measurements in patients with chronic obstructive pulmonary disease.

A M Schols1, A M Dingemans, P B Soeters, E F Wouters.   

Abstract

The relative contribution of a meal, exercise and diuretic therapy to within day variation of resistance values from bioelectrical impedance measurements was studied in several groups of patients with severe Chronic Obstructive Pulmonary Disease (COPD). All patients were in a stable clinical condition. Fasting resistance (RES) in the early morning was significantly higher than RES values during the day ((mean +/- SD): 26 +/- 21 Ohms, p < 0.001). Relative to a non-fasting pre-meal value no significant decrease in RES was measured within 4h after ingestion of the meal. RES did not change significantly after a submaximal exercise challenge on the bicycle ergometer. No consistent effect of oral diuretics (40 mg furosemide), was established within 5h after administration. Measurements on two consecutive days at the same time in the nourished state, were highly reproducible: mean change 4 +/- 20 Ohms, NS). We conclude that in patients with stable COPD, within day variation has only a slight impact on the estimation of fat free mass for between-patient comparison, but it is important to take this into account during follow up studies.

Entities:  

Year:  1990        PMID: 16837369     DOI: 10.1016/0261-5614(90)90035-q

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  9 in total

1.  Decreased mechanical efficiency in clinically stable patients with COPD.

Authors:  E M Baarends; A M Schols; M A Akkermans; E F Wouters
Journal:  Thorax       Date:  1997-11       Impact factor: 9.139

2.  Could bioelectric impedance spectroscopy (BIS) measured appendicular intracellular water serve as a lean mass measurement in sarcopenia definitions? A pilot study.

Authors:  E Siglinsky; B Buehring; D Krueger; N Binkley; Y Yamada
Journal:  Osteoporos Int       Date:  2018-03-25       Impact factor: 4.507

3.  Body composition and exercise performance in patients with chronic obstructive pulmonary disease.

Authors:  A M Schols; R Mostert; P B Soeters; E F Wouters
Journal:  Thorax       Date:  1991-10       Impact factor: 9.139

4.  TNF-α is associated with loss of lean body mass only in already cachectic COPD patients.

Authors:  Tomas M L Eagan; Esteban C Gabazza; Corina D'Alessandro-Gabazza; Paloma Gil-Bernabe; Shinya Aoki; Jon A Hardie; Per S Bakke; Peter D Wagner
Journal:  Respir Res       Date:  2012-06-18

5.  A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease.

Authors:  Nicholas S Hopkinson; Rachel C Tennant; Mark J Dayer; Elisabeth B Swallow; Trevor T Hansel; John Moxham; Michael I Polkey
Journal:  Respir Res       Date:  2007-03-13

6.  The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma.

Authors:  A J Staal-van den Brekel; A M Schols; M A Dentener; G P ten Velde; W A Buurman; E F Wouters
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Total and regional fat-to-muscle mass ratio measured by bioelectrical impedance and risk of incident type 2 diabetes.

Authors:  Ningjian Wang; Ying Sun; Haojie Zhang; Chi Chen; Yuying Wang; Jihui Zhang; Fangzhen Xia; Christian Benedict; Xiao Tan; Yingli Lu
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-09-30       Impact factor: 12.910

Review 8.  The theory and fundamentals of bioimpedance analysis in clinical status monitoring and diagnosis of diseases.

Authors:  Sami F Khalil; Mas S Mohktar; Fatimah Ibrahim
Journal:  Sensors (Basel)       Date:  2014-06-19       Impact factor: 3.576

9.  Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy.

Authors:  Chris Burtin; Jacques Bezuidenhout; Karin J C Sanders; Anne-Marie C Dingemans; Annemie M W J Schols; Stephanie T H Peeters; Martijn A Spruit; Dirk K M De Ruysscher
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-11       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.